Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davood Fathi

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Iranian Journal of Immunology : IJI|June 29, 2022
Fibroblast Growth Factor-2 Levels are Elevated in The Serum of Patients with Multiple SclerosisMaryam Jari, Javad Sadeghi Allah Abadi, Davood Fathi, et al.
Muscle & Nerve|April 1, 2021
Telephone consultation for myasthenia gravis care during the COVID-19 pandemic: Assessment of a novel virtual myasthenia gravis indexDeepak Menon, Sara Alnajjar, Carolina Barnett, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 13, 2021
The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosisPayam Sarraf, Sama Bitarafan, Shahriar Nafissi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 2, 2016
Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life settingKatja Kollewe, Claus M Escher, Dirk U Wulff, et al.
Cellular and Molecular Neurobiology|May 30, 2009
CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian populationMajid Shahbazi, Hamid Ebadi, Davood Fathi, et al.
Muscle & Nerve|May 3, 2024
Whole-body magnetic resonance neurography in patients with chronic inflammatory demyelinating polyneuropathyDavood Fathi, Ali Naraghi, Lawrence M White, et al.
Clinical Immunology (Orlando, Fla.)|July 3, 2010
High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosisMajid Shahbazi, Danial Roshandel, Hamid Ebadi, et al.
Muscle & Nerve|July 26, 2020
Application of muscle ultrasound for the evaluation of patients with amyotrophic lateral sclerosis: An observational cross-sectional studySahebeh Rajabkhah, Kamyar Moradi, Ali A Okhovat, et al.
Brain and Behavior|January 9, 2021
Central nervous system manifestations in COVID-19 patients: A systematic review and meta-analysisShahrzad Nazari, Amirhossein Azari Jafari, Seyyedmohammadsadeq Mirmoeeni, et al.
Cerebellum (London, England)|June 22, 2022
Clinical and Molecular Findings of Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay: an Iranian Case Series Expanding the Genetic and Neuroimaging SpectraMahmoud Reza Ashrafi, Pouria Mohammadi, Ali Reza Tavasoli, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Iranian Journal of Immunology : IJI|June 29, 2022
Fibroblast Growth Factor-2 Levels are Elevated in The Serum of Patients with Multiple SclerosisMaryam Jari, Javad Sadeghi Allah Abadi, Davood Fathi, et al.
Muscle & Nerve|April 1, 2021
Telephone consultation for myasthenia gravis care during the COVID-19 pandemic: Assessment of a novel virtual myasthenia gravis indexDeepak Menon, Sara Alnajjar, Carolina Barnett, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 13, 2021
The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosisPayam Sarraf, Sama Bitarafan, Shahriar Nafissi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 2, 2016
Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life settingKatja Kollewe, Claus M Escher, Dirk U Wulff, et al.
Cellular and Molecular Neurobiology|May 30, 2009
CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian populationMajid Shahbazi, Hamid Ebadi, Davood Fathi, et al.
Muscle & Nerve|May 3, 2024
Whole-body magnetic resonance neurography in patients with chronic inflammatory demyelinating polyneuropathyDavood Fathi, Ali Naraghi, Lawrence M White, et al.
Clinical Immunology (Orlando, Fla.)|July 3, 2010
High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosisMajid Shahbazi, Danial Roshandel, Hamid Ebadi, et al.
Muscle & Nerve|July 26, 2020
Application of muscle ultrasound for the evaluation of patients with amyotrophic lateral sclerosis: An observational cross-sectional studySahebeh Rajabkhah, Kamyar Moradi, Ali A Okhovat, et al.
Brain and Behavior|January 9, 2021
Central nervous system manifestations in COVID-19 patients: A systematic review and meta-analysisShahrzad Nazari, Amirhossein Azari Jafari, Seyyedmohammadsadeq Mirmoeeni, et al.
Cerebellum (London, England)|June 22, 2022
Clinical and Molecular Findings of Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay: an Iranian Case Series Expanding the Genetic and Neuroimaging SpectraMahmoud Reza Ashrafi, Pouria Mohammadi, Ali Reza Tavasoli, et al.
Pageof 4